期刊文献+

冠心病患者尿酸与外周动脉阻塞性疾病的相关性研究 被引量:11

Study on the independent association of uric acid levels with peripheral arterial disease in Chinese patients with coronary heart disease
原文传递
导出
摘要 目的评价冠心病患者尿酸与外周动脉阻塞性疾病(PAD)的关系.方法连续入选上海第十人民医院等32家医院的冠心病住院患者(年龄≥50岁)3251例为研究对象;使用SPSS 11.5软件建立数据库并进行统计分析;测量踝臂指数(ABI)并检测尿酸水平;ABI〈0.9诊断为PAD;在多因素logistic分析中调整混杂变量(P〈0.10);通过受试者工作特征曲线(ROC曲线)确定尿酸作为冠心病患者PAD诊断的参考指标的最佳界值.结果在单变量分析中,PAD组尿酸水平及高尿酸血症患病率明显高于非PAD组(P〈0.001);把尿酸水平五等份后各等级的PAD患病率依次为23.2%、27.4%、36.1%、43.2%、72.7%(趋势x2检验,P〈0.05);尿酸作为连续性变量在多因素logistic分析中OR值为1.002(95%CI:1.001~1.002);通过ROC曲线得到尿酸作为冠心病患者PAD诊断的参考指标的最佳界值为227.2 μmol/L,灵敏度为0.846,特异度为0.203,曲线下面积为0.521(95%CI:0.504~0.547);以此界值划分尿酸水平为二分类变量,在多因素logistic分析中OR值为1.292(95%CI:1.047~1.596),剔除使用利尿剂的研究对象后得到类似的结果.结论冠心病患者(年龄≥50岁)的尿酸是PAD一个显著的、独立的危险因素. Objective To evaluate the relationship between uric acid(UA) and peripheral arterial disease(PAD) in Chinese patients with coronary heart disease (CHD). Methods UA levels and PAD were evaluated in 3251 Chinese hospitalized patients with CHD (age≥50 years). PAD was diagnosed when the ankle-brachial index was 〈 0.9 but patients with an ankle-brachial index of 〉 1.4 were excluded because of false negative rate. Potential confounding variables with P〈 0.10 were adjusted for multivariate analysis. Results In univariate analysis, UA levels were higher in patients with PAD than in those without PAD (349.80 μmol/L± 128.45 μmol/L vs. 323.00 μmol/L± 110.72 μmol/L, P〈 0.001). Rate of hyperuricemia in patients with PAD and without PAD were 31.62% and 22.48% (P〈 0.001 ) respectively. Prevalence rates of PAD for quintiles of UA level were 23.2 %, 27.4 % , 36.1%, 43.2 % and 72.7 % ,respectively (P-trend 〈 0.05). With UA level as a continuous variable, the multivariate-adjusted odds ratio for PAD was 1. 002 (95 % confidence interval : 1.001-1. 002) ( P 〈 0.001 ). The optimal cut-off point for UA as determined by the receiver operating characteristic curve, was 227.2μmol/L. The sensitivity and specificity at this cut-off point were 84.6 % and 20.3 %, respectively. The area under curve was 0. 521(95 % condidence interval: 0. 504-0. 547) and the multivariate-adjusted odds ratio for PAD for UA above this level was 1. 292 (95 % confidence interval: 1. 047-1. 596) ( P 〈 0.01 ). The results, however, after exclusion those cases who used diuretics, were similar. Conclusion Elevated uric acid level seemed a significant and independent risk factor for PAD in Chinese hospitalized patients with CHD(age≥50 years).
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2006年第2期161-164,共4页 Chinese Journal of Epidemiology
关键词 冠心病 外周动脉阻塞性疾病 踝臂指数 危险因素 尿酸 Coronary heart disease Peripheral arterial disease Ankle-brachial index Risk factor Uric acid
  • 相关文献

参考文献9

  • 1Ostergen J,Sleight,Dagenais,et al.Mortality over a period of 10years in patients with peripheral arterial disease.N Engl J Med,1992,326:381-386.
  • 2Criqui MH,Langer RD.For the Trans Atlantic Inter-Society Consensus (TASC) Working Group.Management of peripheral arterial disease(PAD).J Vasc Surg,2000,31:s1-s296.
  • 3严江涛,汪道文.尿酸与心血管疾病关系的研究进展[J].临床内科杂志,2005,22(1):7-9. 被引量:42
  • 4Cannon PJ,Stason WB,De martini FE,et al.Hyperuricemia in primary and renal hypetention.N Engl J Med,1996,275:457-464.
  • 5Tseng CH.Independent association of uric acid levels with peripheral arterial disease in Taiwan Residents patients with type 2 diabetes,diabetes UK.Diabetes Medicine,2004,21:724-729.
  • 6Hiatt WR.Medical treatment of peripheral arterial disease and claudication.N Engl Med,2001,344:1608-1621.
  • 7Chu NF,Wang DJ,Liou SH,et al.Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan.Eur J Epidemiol,2000,16:13-17.
  • 8Chou P,Soong LN,Lin HY.Community-based epidemiological study on hyperuricemia in Pu-li,Taiwan.J Formus Med Assoc,1993,92:597-602.
  • 9Sweet JA.Measuring the accuracy of diagnostic systems.Science,1988,240:1285-1293.

二级参考文献22

  • 1Rao GN, Corson MA, Bcrk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor Achain expression. J Biol Chem, 1991,266:8604-8608.
  • 2Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol,2002,282 : F991-997.
  • 3Freedman DS,Williamson DF,Gunter EW,et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-Up Study. Am J Epidemiol, 1995,141:637-644.
  • 4Cannon P J, Stason WB, Demartini FE, et al. Hyperuricemia in primary and renal hypertension. N Engl J Med, 1966,275:457-464.
  • 5Feig D Iand R J. JohnsonHypenuicemia in Childhood Primary Hypertension. Hypertension,2003,42 : 247-252.
  • 6Mazzali M,Hughes J,Kim YG,et al. Elevated uric acid increases bloodpressure in the rat by a novel crystal-independent mechanism. Hypertension,2001,38:1101-1106.
  • 7Watanabe S, Kang DH,Feng L, et al. Uric acid, hominoid evolution ,and the pathogenesis salt-sensitivity. Hypertension,2002,40:355-360.
  • 8Anker SD, Coats AJS. Metabolic, functional, and haemodynamic staging for CHF? Lancet, 1996,348 : 1530-1531.
  • 9Anker SD,Doehner W,Rauchhaus M,et al. Uric Acid and Survival inChronic Heart Failure:Validation and Application in Metabolic, Functional, and Hemodynamic Staging. Circulation,2003,107 : 1991.
  • 10Leyva F,Anker S,Swan JW,et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J,1997,18:858-865.

共引文献41

同被引文献70

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部